| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ML334 diastereomer | CTRPv2 | pan-cancer | AAC | 0.094 | 0.07 |
| mRNA | QL-X-138 | GDSC1000 | pan-cancer | AAC | -0.081 | 0.07 |
| mRNA | Mitomycin-C | GDSC1000 | pan-cancer | AAC | -0.094 | 0.08 |
| mRNA | KIN001-244 | GDSC1000 | pan-cancer | AAC | 0.082 | 0.08 |
| mRNA | momelotinib | CTRPv2 | pan-cancer | AAC | -0.075 | 0.08 |
| mRNA | erastin | CTRPv2 | pan-cancer | AAC | -0.075 | 0.08 |
| mRNA | valdecoxib | CTRPv2 | pan-cancer | AAC | -0.076 | 0.08 |
| mRNA | KIN001-055 | GDSC1000 | pan-cancer | AAC | -0.088 | 0.08 |
| mRNA | itraconazole | CTRPv2 | pan-cancer | AAC | -0.082 | 0.08 |
| mRNA | serdemetan | FIMM | pan-cancer | AAC | 0.42 | 0.08 |